Does MD Anderson do clinical trials?
MD Anderson conducts one of the world’s largest clinical trials programs, offering thousands of clinical trials covering prevention, diagnosis, treatment and survivorship.
How many clinical trials does MD Anderson have?
MD Anderson has more than 160 clinical trials open testing drugs and cellular therapies that stimulate and support immune attack against many different types of cancer.
How do I enroll in MD Anderson clinical trials?
Request an appointment at MD Anderson online or by calling 1-877-632-6789.
Who qualifies for clinical trials?
Each study has its own rules about who can — or cannot — participate. This is called “eligibility.” Your eligibility may be based on your age, gender, overall health, type and stage of a disease, treatment history, and other conditions. Not everyone is chosen to participate.
Are clinical trials worth it?
What are the Benefits of a Clinical Trial? You may get a new treatment for a disease before it is available to everyone. You play a more active role in your own health care. Researchers may provide you with medical care and more frequent health check-ups as part of your treatment.
What is the difference between Phase 2 and 3 trials?
Doctors also look for signs that cancer responds to the new treatment. Phase II trials test if one type of cancer responds to the new treatment. Phase III trials test if a new treatment is better than a standard treatment. Phase IV trials find more information about long-term benefits and side effects.
Does MD Anderson use immunotherapy?
The immunotherapy platform provides MD Anderson investigators with support for immunotherapies in the treatment of a wide variety of tumor types and helps to link immunologic data with the genomic and proteomic platforms.
Who Cannot participate in clinical trials?
Some trials only include people in a certain age group, or of one sex, or at a particular stage of their illness. The exclusion criteria state who cannot take part in the trial. For example, people who are already taking particular medicines may be excluded as these may affect the trial treatment.
How much do you get paid for clinical trial?
Overall, the median clinical trial compensation was US$3070 (range = US$150-US$13,000). Participants seeking new healthy volunteer trials tended to screen for three studies per year, participate in one or two studies, and earn roughly US$4000 annually.
What are Phase 4 clinical trials?
A type of clinical trial that studies the side effects caused over time by a new treatment after it has been approved and is on the market. These trials look for side effects that were not seen in earlier trials and may also study how well a new treatment works over a long period of time.
How do I get referred to MD Anderson?
Referrals can be made by:
- Phone: Call our Referring Provider Team at 1-877-632-6789 and select option 1.
- Email: Email our Referring Provider Team at [email protected].
- Fax: Fax the patient referral form (pdf) to 713-563-2449.
How to schedule an appointment with an MD Anderson Cancer Center at Cooper?
To schedule an appointment with an MD Anderson Cancer Center at Cooper cancer specialist, please call 855.MDA.COOPER(855.632.2667). Appointments 855.MDA.COOPER (855.632.2667) 855.632.2667 Request an Appointment Section Menu Sidebar Menu MD Anderson Cancer Center at Cooper Additional Resources Cancer Care Support Services Cancer Clinical Trials
Why choose MD Anderson for clinical trials?
MD Anderson conducts one of the world’s largest clinical trials programs, offering thousands of clinical trials covering prevention, diagnosis, treatment and survivorship. MD Anderson’s Referring Provider Team can help physicians identify the appropriate research staff to discuss clinical trials and eligibility criteria specific to their patients.
Do patients go through the phases of a clinical trial?
Although a treatment moves through the phases, a patient does not. Clinical trials don’t just examine new drugs. Although many clinical trials study new medicines, some study new ways to dispense treatment, explore a new dosage or test a drug’s success in treating different cancer types.